fexofenadine + ranitidine

Fexofenadine + ranitidine is a combination of two small molecule drugs, each with distinct mechanisms of action. Fexofenadine is a second-generation antihistamine that acts as a selective antagonist at the histamine H1 receptor, thereby blocking the effects of endogenous histamine and alleviating symptoms associated with allergic rhinitis and urticaria. Ranitidine is an H2 receptor antagonist that reduces gastric acid secretion by competitively inhibiting histamine at parietal cell H2 receptors in the stomach, used for conditions such as peptic ulcer disease and gastroesophageal reflux disease (GERD). The rationale for combining an H1 antagonist (fexofenadine) with an H2 antagonist (ranitidine) lies in evidence suggesting superior efficacy in treating certain acute allergic disorders—such as urticaria—compared to monotherapy with either agent alone[9][5]. This combination targets both peripheral allergy symptoms and potential gastrointestinal manifestations or triggers.